Malignant Hypopharyngeal Neoplasm — Trials

Malignant Hypopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

191 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 53
Recruiting: 31
Ph III recruiting: 5
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.4%
Trials / 1,000 deaths: 109.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05245682	Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer	active not recruiting	Early Phase 1	10	Emory UniversityOTHER	1	Aug 21, 2026	clinicaltrials
NCT06914999	Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer	recruiting	Early Phase 1	20	Emory UniversityOTHER	1	Oct 22, 2025